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S umma ry 
Utilizing a nine amino-acid (Asp-Glu-Leu- 
Tyr-Pro-Leu-Glu-Val-Glu) non-enkephalin contain- 
ing fragment of Peptide F from the pro-enkepha- 
lin molecule, a radioimmunoassay was developed. 
Extraction of bovine, rat, and guinea pig 
adren~nedullary preparations demonstrated this 
fragment to be present and apparently partially 
conserved across species. In rats, acute ines- 
capable foot-shock stress led to a significant 
decrease of the immunoreactive material in the 
adrenal medulla. Chronic daily stress for two 
weeks resulted in an inability of the adrenals 
to alter F levels upon subsequent stress. The 
existence of F-like immunoreactivity and its 
alteration by environmental manipulation, 
suggest that it may play a unique physiological 
role. 
A number of findings have led to the rapid isolation and 
final sequencing of pro-enkephalin in the adrenal medulla 
(1,2,3). Initially, these findings included the discovery of 
the presence of enkephalin-like immunoreactivity in the adrenal 
gland (4,5), and later the isolation of the immunoreactivity to 
the adrenomedullary chromaffin granules (5,6). Further work 
revealed a number of enkephalin containing fragments in 
chromaffin granules characterized by the presence of more than 
one copy of a biologically active peptide per fragment and their 
stability after enzymatic degradation (7). Peptide F, a 
thirty-four amino acid fragment (molecular weight 3840 daltons), 
was one of the initial sequences of the adrenal medulla 
pro-enkephalin molecule to be isolated and sequenced. 
The question of whether the non-enkephalin portion of the 
enkephalin precursor possesses any biological function is of 
importance. The enkephalins are flanked with dibasic residues 
suggesting trypsin-like cleavages and the possibility of 
producing novel peptides which could be stored and co-released 
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with the enkephalins. We therefore developed a radioimmunoassay 
for the midportion of the F peptide. We have examined the 
regional distribution of F in the rat brain. We have begun 
chromatographic studies to characterize the adrenal 
immunoreactivity. We have also studied physiological changes 
caused by a stress paradigm, which induces opioid-mediated 
stress analgesia (8). 
The stress paradigm involves administration of acute 
footshock to the rat to produce naloxone reversible analgesia. 
When shock is delivered chronically over a period of two weeks 
"tolerance" appears to develop such that further stress is no 
longer effective in altering pain. Studies have implicated the 




Peptide F fraqment. The nine-amino acid sequence was 
chosen because it did not include the enkephalin structures, had 
no complex amino-acids and had a tyrosine for iodination. This 
peptide was synthesized via solid phase method, coupled via 
glutaraldehyde to thyroglobulin and injected into rabbits. A 
number of antisera were developed and tested for cross- 
reactivity prior to their use in the radioimmunoassay. The 
assay was carried out in potassium phosphate buffer (150mM, 
pH8.2, 1% NaCI, 3% BSA). After an 18 hr incubation, the 
charcoal-dextran technique was used for separation of bound from 
free 125I F peptide. 
Tissue Preparation 
Bovine adrenals were obtained from a slaughterhouse and 
stored on ice (15 min after death). The adrenal medullas were 
dissected out and the chr~naffin granules were prepared by a 
standard procedure with a single modification (12). After 
isolation the chromaffin granules were homogenized in a solution 
of 1 M acetic acid, 1 mM HCI for 30 seconds. 
Rat and guinea pig adrenal medullas, and rat brains were 
obtained immediately following the decapitation of the animals. 
The adrenal medullas were dissected out and frozen on dry ice 
until the time of further processing. The adrenal medulla from 
each animal were then homogenized in an acid:acetone solution 
containing iodoacet~mide, and phenylmethylsulfonylfluoride. 
After the completion of their extraction, tissue specimens were 
then lyophilized until dry. The rat brains were dissected at 
the time of decapitation, and sections or regions were processed 
in the acid:acetone solution (75 vol/wt). 
Stress Experiment 
Twenty-eight adult male Sprague-Dawley rats were divided 
into four groups. One group served as non-shocked control. A 
second group received 30 min of intermittant footshock (5 mA, 1 
sec duration, once per 5 sec) immediately before sacrifice 
(acute group). A third group received the same treatment daily 
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for 14 days prior to the day of sacrifice. No shock was 
administered on the last day (chronic group). A final group was 
identical to the chronic group except the animals were also 
shocked i~nediately before decapitation (chronic-acute). 
Results 
The antiserum chosen showed no cross-reactivity with 
Met-enkephalin, Leu-enkephalin, ACTH (1-27), alpha-MSH, or 
Beta-endorphin in our radioimmunoassay. The IC.^ was 300 
bu 
fmoles/ml over a number of successive assays. Chromatography of 
extracts of rat adrenal medulla on Biogel P-2, with 2N acetic 
acid gave a single peak of immunoreactive material. The peak 
corresponded to a molecular weight of less than 1500. 
Bovine adrenomedullary chromaffin granules, rat and guinea 
pig adrenal preparations demonstrated the presence of both 
Leu-enkephalin immunoreactivity and Peptide F fragment 
immunoreactivity. 
The results from the stress experiment are shown in Table 
I. Our data was analyzed using 4 (conditions) X 3 (trials) 
repeated measures by ~alysis of variance (ANOVA). The results 
showed that a statistically significant effect was found from 
these conditions (F 3,24 = 4.76; p<.01). Post hoc analysis 
using Neuman Keuls indicated that the control group differed 
significantly from the acute stress group (P<.05). In addition, 
after chronic stress the quantity of Peptide F immunoreactivity 
was reduced and failed to show a response to acute stress. 
TABLE I 
Effect of Stress on the Levels of Peptide F 
Fragment Immunoreactivity in Adrenal Medullas 
Stress Condition Peptide F Fragment IR 
(Fmoles/mg wet weight) 
Control (n=7) 83.48 + 8.42 
Acute Stress (n=7) 35.86 + 6.34 
Chronic Stress (n=7) 52.71 + 6.20 
Chronic/Acute 
Stress (n=7) 61.33 + 8.00 
Values are means + SE. 
Discussion 
The present study demonstrates that an antiserum can be 
successfully developed which will allow the study of the 
pro-enkephalin fragments not only in adrenal medulla, but in 
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brain. The Peptide F fragment appears to be partially conserved 
across species as de~nonstrated by its presence in bovine, guinea 
pig, and rat adrenal !nedullas, as well as several regions of rat 
brain. The site of the material suggests that it is forther 
processed beyond cleavage away fro,n the enkephalin. The exact 
identity of the pe~tide(s) bein~ measured is under further 
study. The stress e×periment demonstrated that F-like material 
responds to environinenta] manipul~tion, q~]e [nitial draulatic 
loss after 30 min is consistent with release of the material 
from the gland. The lack of further responsiveness to acute 
stress [n the chronically treated animals is consistent with the 
loss of behavioral ana!ges [a after repeated stress. Taken 
together, these rest]its suggest a possible physiological role of 
the F-like material. 
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